Codonics strikes private label dealAurora brokers Chinese exchangeZiehm changes leadership
The computed radiography and film digitizing firm iCRco will globally distribute Codonics printer and media products under its own label as part of a partnership agreement announced Sept. 16. Software introduced by iCRco in January 2006 will complement the privately labeled products from Codonics.
Researchers from China will spend up to three weeks in leading breast centers in the U.S. to learn about breast imaging modalities under a program established by the China Medical Women's Association (CMWA) and the Aurora Breast MRI Society. CMWA has 19 branches with 150 institutional members and more than 20,000 individual women physician members. The Aurora Breast MRI Society is sponsored by Aurora Imaging Technology. Dr. Zi-yang Li, executive vice president of CMWA, affirmed that new technology, Aurora Dedicated Breast MRI System, is needed in the fight against breast cancer in China.
Dr. Jörg Ströbel has stepped down as managing partner of Ziehm Imaging-Aton. In his seven years at the corporate helm, Ströbel transformed Ziehm Imaging into a major innovator of mobile C-arm technology, according to the company. Klaus Hörndler and Stefan Gutsch have taken over as managing directors.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.